This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Oct;12(10):581.

doi: 10.1038/nrneph.2016.122. Epub 2016 Aug 8.

Kidney cancer: OCT2 demethylation cracks open oxaliplatin resistance

PMID: 27498955
DOI: 10.1038/nrneph.2016.122

Comment

Kidney cancer: OCT2 demethylation cracks open oxaliplatin resistance

Andrea Aguilar. Nat Rev Nephrol. 2016 Oct.

. 2016 Oct;12(10):581.

doi: 10.1038/nrneph.2016.122. Epub 2016 Aug 8.

Author

PMID: 27498955
DOI: 10.1038/nrneph.2016.122

No abstract available

PubMed Disclaimer

Comment on

Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin.
Liu Y, Zheng X, Yu Q, Wang H, Tan F, Zhu Q, Yuan L, Jiang H, Yu L, Zeng S. Liu Y, et al. Sci Transl Med. 2016 Jul 20;8(348):348ra97. doi: 10.1126/scitranslmed.aaf3124. Sci Transl Med. 2016. PMID: 27440728

References

1. Sci Transl Med. 2016 Jul 20;8(348):348ra97 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations